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AbsTrACT
Aims  To determine a normative of tumbling E optotype 
and its feasibility for visual acuity (VA) assessment in 
children aged 3-4 years.
Methods A cross-sectional study of 1756 children 
who were invited to participate in a comprehensive 
non-invasive eye exam. Uncorrected monocular VA 
with crowded tumbling E with a comprehensive 
ophthalmological examination were assessed. Testability 
rates of the whole population and VA of the healthy 
children for different age subgroups, gender, school type 
and the order of testing in which the ophthalmological 
examination was performed were evaluated.
results The overall testability rate was 95% (92% and 
98% for children aged 3 and 4 years, respectively). The 
mean VA of the first-day assessment (first-VA) and best-
VA over 2 days’ assessments was 0.14 logMAR (95% 
CI 0.14 to 0.15) (decimal=0.72, 95% CI 0.71 to 0.73) 
and 0.13 logMAR (95% CI 0.13 to 0.14) (decimal=0.74, 
95% CI 0.73 to 0.74). Analysis with age showed 
differences between groups in first-VA (F(3,1146)=10.0; 
p<0.001; η2=0.026) and best-VA (F(3,1155)=8.8; 
p<0.001; η2=0.022). Our normative was very highly 
correlated with previous reported HOTV-Amblyopia-
Treatment-Study (HOTV-ATS) (first-VA, r=0.97; best-VA, 
r=0.99), with 0.8 to 0.7 lines consistent overestimation 
for HOTV-ATS as described in literature. Overall false-
positive referral was 1.3%, being specially low regarding 
anisometropias of ≥2 logMAR lines (0.17%). Interocular 
difference ≥1 line VA logMAR was not associated with 
age (p=0.195).
Conclusions This is the first normative for European 
Caucasian children with single crowded tumbling E in 
healthy eyes and the largest study comparing 3 and 4 
years old testability. Testability rates are higher than 
found in literature with other optotypes, especially in 
children aged 3 years, where we found 5%–11% better 
testability rates.
InTroduCTIon
Although WHO and the National Academy of 
Sciences Committee on Vision (NASCV) have 
issued recommendations about the design of 
optotypes used in visual acuity (VA) charts that 
were included in international guidelines,1 several 
charts used with children meet these criteria: LEA 
symbols, Sloan letters/numbers, tumbling E and 
HOTV. Although HOTV test is commonly used 
in the USA,2–4 no standard VA testing in children 
has been accepted worldwide.5 6 Directional opto-
types as Landolt C and tumbling E charts are widely 
used in non-spoken English countries.5 7 They are 
considered better optotypes as grating recognition 
and orientation is superior to letter recognition8 
and the progression of resolution angles is similar 
throughout the test.9 Tumbling E has the advantage 
of performing better than Landolt C for astigma-
tism against-rule.10 Test–retest tumbling E studies 
demonstrated highly repeatable results (r=0.97).11 
Nevertheless, tumbling E has been reported as 
conceptually difficult for young children1 as it 
requires spatial orientation skills, and recently, it 
has been non-recommended in young children as 
‘they may not yet have developed the ability to 
express the orientation of these optotypes’.4 Doubts 
whether up-down-right-left orientation is already 
mastered by children aged 3 years old (yo), or not, 
is doubtful.
Although single optotypes have better coop-
eration in children if crowding is not used,4 12 
crowded bars are more accurate4 13 to overcome 
the ‘crowding phenomenon’ present in amblyopia 
and should be used.14 In amblyopic children, the 
kind of crowded optotype also revealed differ-
ences depending on the optotype.15 Normative 
with single crowded HOTV2 3 16 and LEA12 have 
been published. Regarding tumbling E, normative 
are either in charts,5 7 17 lines18 or single E without 
crowded bars,18 but to the best of our knowledge, 
no normative with single-crowded tumbling E is 
available in the optimal age screening,19 making it 
crucial to set a normative.
Normal VA in healthy eyes should be strictly 
assessed when setting a normative with accurate 
referral criteria for vision screening. It must be 
ensured that all ophthalmological pathologies 
are excluded. Some recent normative had these 
important considerations into account,3 12 16 17 but 
none with single-crowded tumbling E.
The scope of this study is to determine a norma-
tive for 3–4 yo in healthy eyes with tumbling E 
in the single-crowded form and to determine if it 
is a feasible VA tool in this age group. We search 
for differences between 3 and 4 yo in testability, 
false-positive referrals and we compare it with 
other previous normative published. A normative 
regarding age will be presented.
MATerIAls And MeThods
Participants
Between May 2014 and June 2016, all children 
registered in Portuguese National Health Service 
with 3–4 yo, attending public and private schools in 
762 Guimaraes S, et al. Br J Ophthalmol 2018;102:761–766. doi:10.1136/bjophthalmol-2017-310691
Clinical science
Braga, were invited to participate in an eye exam at the Ophthal-
mology Department of the Hospital de Braga. This study was 
approved by the Human Research Ethics Committee of the 
Hospital de Braga and adhered to the tenets of Declaration 
of Helsinki. Written informed consent was obtained from the 
parent/guardian of child before examinations.
Procedures, ophthalmological examination and VA 
assessment
All children underwent a comprehensive non-invasive eye exam 
performed by orthoptists and paediatric ophthalmologists 
trained in the study’s protocol. Age, sex, school source and order 
of testing were registered. Examination included uncorrected 
monocular VA with single-crowded tumbling E (VA assessment 
was always done by experienced orthoptists in children exam-
ination), ocular motility, cover test, Hirshberg, three Plusoptix 
S04 measures, Randot stereoacuity with circles, biomicroscopy 
and funduscopy. All astigmatisms were registered in negative 
cylinders for comparison proposes.
VA was recorded as the smallest optotype size which the 
child identified in all four directions, in order not to misdiag-
nose meridional amblyopia. VA scores were provided in 0.1 
decimal increments, recorded in a decimal scale and converted 
to logMAR for analysis. After a brief training with binocular 
VA, testing was conducted monocularly, always starting with 
the right eye (OD). The eye was occluded with a non-adhesive 
paper occluder, explaining the child it was a ‘pirate game’. The 
child could either use fingers or a plastic E to indicate the direc-
tion of the letter. Half of the children started the exam with VA 
measurement and then went to perform other exams (VA was 
assessed in the end in the remainder). These VA results were 
considered the first visual acuity assessment (first-VA) as some 
children were called for a second evaluation as explained ahead. 
For testability rates, a child was considered testable if it was 
possible to determine monocular first-VA in both eyes. Stereo-
acuity measurements were done with Randot test. Emetropia 
was defined as: normal spherical equivalent (SE) based on 
98.6% negative predictive value (NPV) for hyperopia adapted 
criteria (SE <2.0 dioptres) and 98% NPV for astigmatism (<1.5 
dioptres) for Plusoptix.20 Myopia and anisometropia criteria 
were SE <−0.5 dioptres and sphere or cylinder <1.0 differ-
ence, respectively. We applied these criteria for all three consec-
utive Plusoptix measurements.
If emetropic children with no associated ophthalmolog-
ical pathology had poor collaboration or a monocular first-VA 
without correction ≤0.6 or interocular difference ≥3 lines in 
decimal scale, children’s VA was reassessed on a second day, this 
time in their parent’s presence. In the second VA assessment, 
the same protocol was applied. We considered the best VA (best-
VA) over the first and second evaluation only for comparison 
purposes with other recent normative published.16 Neverthe-
less, we used first-VA as our main normative outcome variable 
because it best reflects screening practice and, besides, using the 
best of multiple measures of VA could introduce a systematic 
bias, causing false conclusions.21
exclusion/inclusion criteria
Only children aged between 36 and 59 months were included. 
After excluding 12 children that came twice to the exam, the 
whole population of 1735 was considered for testability assess-
ment. For VA normative, only healthy eyes were considered and 
exclusion criteria are presented in figure 1.
sTATIsTICAl AnAlysIs
Data were gathered in Microsoft Office Excel and exported to 
IBM Statistical Package for the Social Sciences Statistics (SPSS 
V.24) for statistical analysis. VA was measured in a decimal 
scale and converted into logMAR units for statistical analyses 
as recommended.22 For being more comprehensive, VA means, 
differences of means, SD and CIs were also expressed in decimal 
values right after all logMAR results (into parenthesis). The statis-
tical procedures assumptions, such as normality, homogeneity of 
variances, were considered. When appropriate, Student's paired-
sample t-test, independent-sample t-test, one-way analysis of 
variance or Welch test were used whether there was homoge-
neity of variances or not in Levene’s test, and the corresponding 
post hoc testing was done, either with Bonferroni or Games-
Howell, if there was statistical significance. When Levene’s test 
indicated unequal variances, df was adjusted correspondingly. 
Effect size measures along with statistical significance (p<0.05) 
were presented.
resulTs
Participation rate of the invited children was 96%. Regarding 
testability, we found 89/1735 (5.1%) non-cooperative children 
in VA responses in at least one eye. Testability in age subgroups 
is presented in table 1.
Testability in different age subgroups of 3.0 (36–41 months), 
3.5 (42–47 months), 4.0 (48–53 months) and 4.5 (54–59 
months) yo. On the right, comparison between 3 and 4 yo.
Of the 1182 children that met the criteria for sample VA 
normative (figure 1), median age was 47.37±4.74 months, 
51.0% were males, 54% attended public schools and in 43% 
ophthalmological examination started with VA assessment. The 
mean first-VA was 0.14 logMAR (95% CI 0.14 to 0.15) (0.72 
(95% CI 0.71 to 0.73)) for OD and 0.14 logMAR (95% CI 0.14 
to 0.15) (0.72, (95% CI 0.71 to 0.73) for OS. Normality of 
these measures where proven by acceptable values of kurtosis 
and skewness (OD: 0.75; 0.44/OS: 0.94; 0.49) and histogram 
distribution. As first-VA for the OD and OS were not signifi-
cantly different (t(1149)=−0.22, p=0.826, d=0.00646, paired 
sample t-test), (r(1150)=0.67, p<0.001, Pearson's correlation), 
we used first-VA OD as the normative of monocular VA in the 
first observation. Differences ≥1 line VA logMAR was found in 
116 children (9.8%).
From the 157 with at least one criteria for a second evalua-
tion, 94 were re-examined on a second day, for VA re-assess-
ment (participation rate 60%). Differences between the best-VA 
OD and OS were not significant (t(1158)=1.14, p=0.254, 
d=0.0335) (r(1159)=0.62, p<0.001). From now on, we will 
no longer report OD or OS, as we will always report OD results, 
either regarding first-VA or best-VA, unless specified differently.
First-VA and best-VA had no differences regarding gender 
and the order in which the ophthalmological examination 
was performed, respectively, (t(1148)=0.428, p=0.668, 
d=0.026) and (t(558)=0.126, p=0.90, d=0.010) for first-VA, 
and (t(1157)=0.916, p=0.36, d=0.054) and (t(565)=1.13, 
p=0.261, d=0.097) for best-VA. Regarding school type, there 
was a difference of 0.014 logMAR (lower logMAR for public 
schools) found in first-VA (t(1030.7)=−2.85, p=0.005, 
d=0.17).
Regarding first-VA, age had a very small correlation 
(r(1150)=−0.17, p<0.001) and differences found between 
3 and 4 yo were 0.022 logMAR (95% CI 0.012 to 0.031) 
(t(1135.2)=4.6, p<0.001, d=0.27, independent sample t-test). 
With best-VA, similar differences of 0.018 logMAR were 
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observed (95% CI 0.001 to 0.027) (t(1150.4)=4.2, p<0.001, 
d=0.25, independent sample t-test). For comparison with recent 
normative studies, we present normative of first-VA and best-VA 
in four age subgroups in table 2.
Analysis showed differences between groups in first-VA 
(F(3,1146)=10.0; p<0.001; η2=0.026) and best-VA 
(F(3,1155)=8.8; p<0.001; η2=0.022). Post hoc analysis using 
Bonferroni test showed no difference in first-VA between 3.0 and 
3.5 yo (p=0.83). All other subgroups had statistically significant 
differences of 0.01556 logMAR (95% CI 0.0018 to 0.0293), 
p=0.019 between 3.5 and 4.0 yo, 0.02274 logMAR (95% CI 
0.0011 to 0.0444), p=0.036 between 3.0 and 4.0 yo, 0.03906 
logMAR (95% CI 0.0193 to 0.0588), p<0.001 between 3.5 and 
4.5 yo, 0.04624 logMAR (95% CI 0.0204 to 0.0721), p<0.001 
between 3.0 and 4.5 yo, 0.02350 logMAR (95% CI 0.0042 to 
0.0428), p=0.010 between 4.0 and 4.5 yo.
Regarding false-positive referrals, for children aged between 
36 and 47 months, with the recommended cut-off value of 0.4 
logMAR (0.4), we had 1% of false-positive referral. For children 
aged between 48 and 59 months, for the recommended cut-off 
value of 0.3 logMAR (0.5), we had 1.5% of false-positive referral. 
For false-positive referrals regarding anisometropias, we used a 
difference ≥2 logMAR lines between OD and OS as the cut-off 
value. Of the 1182 children, only two had anisometropia. We 
used the second evaluation result as the true diagnosis and none 
of those two had in fact anisometropia, giving a false-positive 
referral of 0.17%.
dIsCussIon
This is the first population-based normative for European 
Caucasian children with single-crowded tumbling E. It is also the 
largest study comparing 3 and 4 yo testability, such an important 
age range for screening purposes.
Our exclusion criteria are similar to others3 16 17 that were 
also judicious about measuring VA in only healthy eyes. Based 
on refractive criteria, we excluded 20.4% children, in line with 
Leone et al16 that excluded 29.9% but in a wider age range (6–72 
months), where more refractive errors are expected to be found.
Although we have higher global testability rates (94.9%), our 
main advantage is in the 3 years' group, where our testability is 
considerably higher (table 3).
Although our global testability was lower than the 97.6% 
reported with HOTV-ATS,23 it is important to note that higher 
testability reported by Kupl et al could have been achieved by 
older children, as 28% of children in that study were 5 yo, 
and children between 3.0 and 3.5 yo were not included. If we 
compare similar age groups, we find 94.3% and 98.3% testability, 
better than 93.3% and 96.7% at 3.5 and 4 yo respectively, found 
Figure 1 Inclusion/exclusion criteria for testability rates and for visual acuity (VA) normative. The interocular difference was measured in decimal 
lines. UCVA, uncorrected visual acuity.
Table 1 Testability
Age n non-cooperative Testability (%)
3.0 3 yo 233 929 36 75 84.5 91.9
3.5 696 39 94.3
4.0 4 yo 638 806 14 14 97.8 98.3
4.5 168 0 100.0
Total 1735 89 94.9
yo, year old.
764 Guimaraes S, et al. Br J Ophthalmol 2018;102:761–766. doi:10.1136/bjophthalmol-2017-310691
Clinical science
with HOTV-ATS.23 Comparing our testability with HOTV-ATS 
in four age subgroups described in 2012,24 our rates are 4.5%, 
1.3%, 2.8% and 2% higher than HOTV-ATS for 3.0, 3.5, 4.0 
and 4.5 yo, respectively, also showing the best benefit for 3.0 yo.
Regarding testability rates, one strong point in our study is 
that it reflects testability of all children before exclusion criteria, 
meaning that testability among children with refractive errors 
and/or amblyopia is also considered. If we had considered only 
normal eyes in our study, the overall testability rate would had 
been 97.3%.
We speculate that this good testability scores could be 
achieved because today’s children stimulation with Smartphones 
and Tablets at very young ages leads to up-down-left-right recog-
nition ability developed sooner and the exam could be experi-
enced as another game. Besides, we realised that children tend to 
cooperate much better if they are ‘in-group’ with schoolteachers 
and colleges than when they come alone with their parents. It 
happens as if the child understands better his/her role of commit-
ment to the performance of the tests, seeing it as a school exten-
sion. As a limitation, our better testability could be due to the 
population studied, as Braga is a modern urban city.
We used first-VA for the normative as it best reflects clinical 
practice. Regarding VA variation with age, there is very small 
intensity of the negative correlation found. Moreover, either in 
first-VA or best-VA age subgroups variation analyses, the biggest 
difference found was between 3.0 and 4.5 yo, but differences 
found between all age subgroups were <0.5 logMAR lines, 
what, in our opinion is not clinically relevant, as the interval 
measurements used in logMAR VA scales are 0.1 logMAR units 
(1 line), making differences of <0.05 logMAR units (<0.5 lines) 
below the threshold scale measurement, so, not possible to 
detect in clinical practice and, for the same reason, would not 
change VA thresholds normative guidelines. Effect size of these 
differences analyses revealed that age only explained 2.6% and 
2.2% of first-VA and best-VA, respectively. Regarding interoc-
ular differences of ≥1 line VA logMAR, we had only 9.8%, 
<26% report16 and it was not associated with age (p=0.195) as 
reported earlier.16
Comparing our best-VA normative (table 4) with the recently 
reported HOTV-ATS,16 we found HOTV-ATS has 0.079 and 
0.072 logMAR consistently better VA than our first-VA and 
best-VA with very high correlations (r=0.97 and r=0.99), 
respectively. It is important to note that this HOTV-ATS norma-
tive is based on the best-VA of two consecutive measures in two 
different appointments, what is the equivalent as our best-VA. 
The same tendency is described in literature regarding HOTV 














118 0.15 (0.14 to 0.17) 0.70 (0.67 to 0.72) 120 0.15 (0.14 to 0.17) 0.70 (0.68 to 0.73)
3.5 yo
(42–47)
453 0.15 (0.14 to 0.16) 0.71 (0.69 to 0.72) 459 0.14 (0.13 to 0.15) 0.73 (0.71 to 0.74)
4 yo
(48–53)
464 0.14 (0.13 to 0.14) 0.73 (0.72 to 0.74) 465 0.13 (0.12 to 0.13) 0.74 (0.73 to 0.76)
4.5 yo
(54–59)
115 0.11 (0.10 to 0.12) 0.77 (0.75 to 0.80) 115 0.11 (0.10 to 0.12) 0.78 (0.75 to 0.80)
VA of the first-VA and of the best-VA over two assessments; yo, years old; VA, visual acuity.






total4 yo 4 yo
Present study Single-crowded tumbling E 929 1735 91.90% 94.9%
806 98.30%
Leone et al24 HOTV-ATS 363 723 86.5% 91.4%
360 96.3%
Pan et al3 HOTV-ATS 460 1027 81% 90.5%
567 98%
Kvarnstrom et al27 HOTV chart 478 707 84.80% 87.4%
229 92.80%
Kvarnstrom et al27 LEA chart 478 707 82.80% 86.1%
229 92.90%








Single LEA symbols 10 28 80.00% 92.80%
18 100.00%
For a more accurate comparison, testability rates are presented separately at 3 and 4 yo.
yo, years old.
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charts and ETDRS charts, where HOTV-ATS has approximately 
1 line better VA results.24
Comparing our best-VA normative with HOTV in different 
age subgroups of 3.0 (36–41 months), 3.5 (42–47 months), 4.0 
(48–53 months) and 4.5 (54–59 months) yo. Note that single 
crowded optotypes and best-VA over two observations are use 
in both studies.
Despite the limitation of this assumption, if we consider school 
type as a proxy of socioeconomic status, the difference of 0.014 
logMAR found in first-VA, although statistically significant, had 
a small effect size, and to our interpretation it should not be 
considered relevant.25
Regarding false-positive referrals, for 3 yo we had 1% of 
false-positive referral, which is similar to the 0.9% found 
by Leone et al,16 using the same cut-offs, with HOTV-ATS 
protocol26 on the electronic VA tester and better than the 5.3% 
they found with ETDRS or HOTV chart.16 For children 4 yo, we 
had 1.5% false-positive referrals, which is 1.1% higher than the 
0.4% found by Leone et al with HOTV-ATS26 and much lower 
than the 6% found with ETDRS or HOTV chart.16 Regarding 
false-positive referrals for anisometropias, we had a very low 
false-positive referral of 0.17%, much lower than 6% described 
by Pan et al with HOTV-ATS.3 Their normative, nevertheless 
represents a wider age range (30–72 months).
As limitations, we only studied Braga's population. We did 
not use race as a variable because being our population mainly 
Caucasian, we assume it reflects no influence in our results. In 
a 235 sample, we only reported two non–Caucasians (0.85%). 
The time of the exam was not assessed. The published differ-
ences of 1.12 more minutes to test a 3 yo child vs 4 yo child with 
LEA and HOTV charts,27 arises the question as if these differ-
ences are relevant, considering the time spent for receiving the 
child, register the results and giving the report of the screening. 
Further studies are needed regarding this issue, including time to 
perform the exams in healthy versus unhealthy eyes.
In summary, tumbling E has the highest testability rates between 
3 and 4 yo when compared with literature, specially in children 3 
yo where it is considerably better. Past evidences fearing the differ-
ences in collaboration between 3 and 4 yo are no longer supported. 
In screenings where VA is the gold standard, tumbling E is a good 
instrument for VA assessment in children aged 3 and 4 years.
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